The Rise of GLP-1 Drugs: A New Era in Chronic Health Management
In the ever-evolving landscape of healthcare, a new class of drugs is making waves for its potential to manage chronic conditions effectively. GLP-1 drugs, such as the widely discussed Ozempic, have been tried by approximately 12 percent of U.S. adults, showcasing a significant shift in chronic disease management strategies1. Understanding GLP-1 Drugs GLP-1, or glucagon-like peptide-1, …